AN2 Therapeutics
ANTX
#10014
Rank
NZ$56.62 M
Marketcap
NZ$2.07
Share price
0.84%
Change (1 day)
-19.43%
Change (1 year)

Earnings for AN2 Therapeutics (ANTX)

Earnings in 2025 (TTM): -NZ$66.01 Million

According to AN2 Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$93.95 Million, an increase over its 2023 earnings that were of -NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AN2 Therapeutics from 2021 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$66.01 Million-29.74%
2024 -NZ$93.95 Million-21.66%
2023 -NZ$0.12 Billion64.77%
2022 -NZ$72.78 Million95.89%
2021 -NZ$37.16 Million